<?xml version=“1.0” encoding=“UTF-8”?> <MedicinalProductIndication xmlns=“hl7.org/fhir”>
<id value="example"/> <meta> <security> <system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/> <code value="HTEST"/> <display value="test health data"/> </security> </meta> <diseaseSymptomProcedure> <coding> <system value="http://ema.europa.eu/example/indicationasdisease-symptom-procedure"/> <code value="Venousthromboembolismprophylaxis"/> </coding> <text value="Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\nor knee replacement surgery.\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients)."/> </diseaseSymptomProcedure> <comorbidity> <coding> <system value="http://ema.europa.eu/example/comorbidity"/> <code value="Hipsurgery"/> </coding> </comorbidity> <intendedEffect> <coding> <system value="http://ema.europa.eu/example/intendedeffect"/> <code value="PRYLX"/> </coding> </intendedEffect> <population> <ageRange> <low> <value value="18"/> <unit value="a"/> </low> </ageRange> </population>
</MedicinalProductIndication>